Core & Main CNM 深 沪
已收盘 09-19 16:00:00 美东时间
50.93
+0.570
+1.13%
华盛通- 最 高51.20
- 今 开50.63
- 成交量 451.57万股
- 最 低 50.02
- 昨 收 50.36
- 总市值 96.77亿
- 52周最高 67.18
- 市盈率 静 23.92
- 换手率 2.38%
- 52周最低 41.60
- 委 比 -96.88%
- 总股本 1.90亿
- 历史最高 67.18
- 量 比 1.29
- 振 幅 2.34%
- 历史最低 18.75
- 每 手 1
- 风险率 6.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
美股周涨跌榜 | 好莱坞或迎巨震！华纳兄弟探索频道周涨超55%；新思科技绩后暴跌28.9%
好莱坞或迎巨震！华纳兄弟探索频道周涨超55%，传Paramount Skydance拟收购公司；新思科技绩后暴跌28.9%>>
09-13 11:42
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
Truist Securities Maintains Hold on Core & Main, Lowers Price Target to $50
Truist Securities analyst Keith Hughes maintains Core & Main (NYSE:CNM) with a Hold and lowers the price target from $56 to $50.
09-11 22:24
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
Core & Main Reports Strong Q2 2025 Performance
Core & Main, Inc. Class A ( ($CNM) ) has released its Q2 earnings. Here is ...
09-10 11:56
12 Industrials Stocks Moving In Tuesday's Intraday Session
Gainers CDT Envirn Tech Inv Hldgs (NASDAQ:CDTG) stock moved upwards by 53.8% t...
09-10 01:06
Core & Main Narrows FY2025 Sales Guidance from $7.600B-$7.800B to $7.600B-$7.700B vs $7.858B Est
Core & Main (NYSE:CNM) narrows FY2025 sales outlook from $7.600 billion-$7.800 billion to $7.600 billion-$7.700 billion vs $7.858 billion estimate.
09-09 19:44
Earnings Scheduled For September 9, 2025
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is projected t...
09-09 16:32
Core & Main Q2 2026 Earnings Preview
Core & Main (NYSE:CNM) is scheduled to announce Q2 earnings results on Tuesday, September 9th, before market open. The consensus EPS Estimate is $0.79 (+29.5% Y/Y) and the consensus Revenue Estimate i...
09-08 22:33
